Long-Term Statin Treatment in Children with Familial Hypercholesterolemia: More Insight into Tolerability and Adherence
Autor: | Albert Wiegman, Frits A. Wijburg, John J.P. Kastelein, Hans J. Avis, Ellen M. A. Smets, D. Meeike Kusters, Marjet J. A. M. Braamskamp, Barbara A. Hutten |
---|---|
Přispěvatelé: | Other departments, Amsterdam Cardiovascular Sciences, Amsterdam Gastroenterology Endocrinology Metabolism, Anesthesiology, Amsterdam Public Health, Medical Psychology, Paediatric Metabolic Diseases, Vascular Medicine, Epidemiology and Data Science |
Jazyk: | angličtina |
Rok vydání: | 2015 |
Předmět: |
Adult
Male medicine.medical_specialty Pharmacological therapy Adolescent Familial hypercholesterolemia law.invention Medication Adherence Hyperlipoproteinemia Type II Young Adult Pharmacotherapy Randomized controlled trial Double-Blind Method law Internal medicine Surveys and Questionnaires medicine Humans Pharmacology (medical) Pediatrics Perinatology and Child Health Original Research Article Young adult Child business.industry nutritional and metabolic diseases Statin treatment medicine.disease Premature atherosclerosis Tolerability Pediatrics Perinatology and Child Health Physical therapy lipids (amino acids peptides and proteins) Female Hydroxymethylglutaryl-CoA Reductase Inhibitors business Follow-Up Studies |
Zdroj: | Paediatric Drugs Paediatric drugs, 17(2), 159-166. Adis International Ltd |
ISSN: | 1179-2019 1174-5878 |
Popis: | Background Statins are currently the preferred pharmacological therapy in individuals with familial hypercholesterolemia (FH) with the aim to prevent premature atherosclerosis. In adults, these agents have been proven to be safe and well tolerated; however, non-adherence is a significant clinical issue. Objectives In this study, we evaluated tolerability and adherence to statin therapy in young adult FH patients 10 years after this was initiated in their childhood. Methods A questionnaire including items on medical history, adherence and reasons for discontinuation was sent to 214 young adult FH patients that initiated statin therapy at least 10 years ago. Tolerability was defined as 100 % minus the percentage of patients that discontinued statin therapy due to side effects. Adherence was defined as the extent to which patients took their medication as prescribed by their physician. We labelled patients adherent if they took 80 % or more of their pills in the month preceding our assessment. Results Follow-up was successful in 205 (95.8 %) subjects (age 18–30 years). A history of side effects was reported by 40 (19.5 %) of the patients, and mainly consisted of muscle complaints and gastrointestinal symptoms. Three patients (1.5 %) discontinued statin therapy because of side effects. Rhadbomyolysis or other serious adverse events were not reported. In fact, 169 (82.4 %) of 205 patients remained on statin treatment and 78.7 % (148 out of 188) were adherent. None of the patient characteristics were significantly associated with adherence. Conclusions Individuals with FH who started statin therapy in childhood demonstrated good adherence during ten years of treatment. Furthermore, statin therapy was well tolerated; only a small minority discontinued therapy because of side effects and the side effects that were reported were mild in nature. |
Databáze: | OpenAIRE |
Externí odkaz: |